Deep brain stimulation in late stage Parkinson’s disease: a retrospective cost analysis in Germany

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neurology

• Publication date

  2005-02-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1007/s00415-005-0640-3PMID 15729530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Health-Related Quality of Life and Healthcare Utilisation in Patients with Parkinson’s Disease

  2012cited by this paper
• Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems

  2005cited by this paper
• Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials.

  2004cited by this paper
• Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  2003cited by this paper
• Deep brain stimulation for Parkinson's disease: Patient selection and evaluation

  2002cited by this paper
• Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus

  2002cited by this paper
• Deep brain stimulation in the treatment of Parkinson’s disease

  2001influential reference
• Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD

  2001cited by this paper
• Évaluation des coûts de la neurochirurgie fonctionnelle des mouvements anormaux par la stimulation des noyaux gris centraux, en particulier du noyau sub-thalamique (NST)

  2000cited by this paper
• Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

  2000cited by this paper
• [Cost assessment of functional neurosurgery for abnormal movement by stimulation of the basal nuclei, particularly the subthalamic nucleus].

  2000cited by this paper
• Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease

  1999cited by this paper
• Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study.

  1999cited by this paper
• Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  1998cited by this paper
• Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease

  1998cited by this paper
• [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

  1998cited by this paper
• Assessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and Medicine.

  1997cited by this paper
• Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease.

  1997cited by this paper
• Assessing the effectiveness of health interventions for cost-effectiveness analysis

  1997influential reference
• Panel on cost-effectiveness in health and medicine.

  1996cited by this paper
• Incorporating quality of life changes into economic evaluations of health care: an overview.

  1996cited by this paper
• How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

  1992cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Fluctuations of disability in Parkinson's disease – clinical aspects

  1981cited by this paper
• Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system.

  1960cited by this paper

• Parkinsonism‐Hyperpyrexia Syndrome Following Deep Brain Stimulation Battery Depletion during the COVID‐19 Pandemic: A Case Series and Review of the Literature

  2025cites this paper
• The costs and benefits of deep brain stimulation in Parkinson's disease: a review and social network analysis

  2025cites this paper
• Electrophysiological approaches to informing therapeutic interventions with deep brain stimulation

  2025cites this paper
• Cost-effectiveness analysis of deep brain stimulation versus treatment as usual for treatment-resistant obsessive-compulsive disorder.

  2025cites this paper
• Global Economic Evaluation of the Reported Costs of Deep Brain Stimulation

  2024cites this paper
• Deep brain stimulation, lesioning, focused ultrasound: update on utility

  2023cites this paper
• Antiparkinsonian Drug Reduction After Directional Versus Omnidirectional Bilateral Subthalamic Deep Brain Stimulation.

  2022cites this paper
• Cost-Effectiveness of Device-Aided Therapies in Parkinson’s Disease: A Structured Review

  2020cites this paper
• Cost‐Effectiveness of Deep Brain Stimulation With Movement Disorders: A Systematic Review

  2019influential citation
• An update on best practice of deep brain stimulation in Parkinson’s disease

  2019cites this paper
• Brain stimulation in obesity

  2017cites this paper
• 2 Cost and Efficacy of Therapies for Advanced Parkinson ' s Disease

  2017influential citation
• Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder.

  2017cites this paper
• Cost analysis of awake versus asleep deep brain stimulation: a single academic health center experience.

  2016cites this paper
• Funkcionális idegsebészeti beavatkozások a mozgászavarok kezelésében

  2016cites this paper
• Economic Analysis of Deep Brain Stimulation in Parkinson Disease: Systematic Review of the Literature.

  2016cites this paper
• Influence of local and circuit-wide modulation of the mesocorticolimbic reward system on the reinstatement of cocaine seeking

  2016cites this paper
• Cost‐utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial

  2016cites this paper
• ESTIMULACIÓN CEREBRAL PROFUNDA EN TRASTORNOS NEUROLÓGICOS Y PSIQUIÁTRICOS

  2016cites this paper
• Deep brain stimulation for obesity: rationale and approach to trial design.

  2015cites this paper
• Estimating the direct and indirect costs associated with Parkinson’s disease

  2015cites this paper
• Ethical Issues in Behavioral Neuroscience

  2015cites this paper
• The medical treatment of patients with Parkinson's disease receiving subthalamic neurostimulation.

  2015cites this paper
• The neuroprotective potential of STN DBS and the role of BDNF

  2015cites this paper
• Deep brain stimulation: a principled and pragmatic approach to understanding the ethical and clinical challenges of an evolving technology.

  2015influential citation
• Cost-effectiveness of subthalmic nucleus deep brain stimulation for the treatment of advanced Parkinson disease in Hong Kong: a prospective study.

  2014cites this paper
• Subthalamic nucleus‐deep brain stimulation for early motor complications in Parkinson's disease—the EARLYSTIM trial: Early is not always better

  2014cites this paper
• Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients

  2014cites this paper
• The Costs and Benefits of Deep Brain Stimulation Surgery for Patients with Parkinson’s Disease at Different Stages of Severity – An Initial Exploration

  2013cites this paper
• Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study

  2013cites this paper
• Pathways of Translation: Deep Brain Stimulation

  2013cites this paper
• Cost‐effectiveness of deep brain stimulation in patients with Parkinson's disease

  2013cites this paper
• Ethics guidance for neurological and psychiatric deep brain stimulation.

  2013cites this paper
• Deep-brain stimulation for Parkinson's disease.

  2012cites this paper
• Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease

  2012influential citation
• Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease.

  2012cites this paper
• Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.

  2012cites this paper
• Current use and potential value of cost-effectiveness analysis in U.S. health care: The case of medicare national coverage determinations

  2012cites this paper
• Towards New Therapies for Parkinson's Disease

  2011cites this paper
• Stymulacja podwzgórza w leczeniu klasterowego bólu głowy

  2011cites this paper
• Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting

  2011cites this paper
• Cost and Efficacy of Therapies for Advanced Parkinson's Disease

  2011influential citation
• [Hypothalamic deep brain stimulation for treatment of cluster headache].

  2011cites this paper
• [Parkinson's disease: cost-of-illness in an outpatient cohort].

  2011cites this paper
• Cost-utility analysis of Parkinson's disease.

  2011cites this paper
• A Medicare benefit expansion: Inpatient clinical and economic outcomes in Deep Brain Stimulation for Parkinson's Disease

  2011cites this paper
• A functionally relevant and long‐term model of deep brain stimulation of the rat subthalamic nucleus: advantages and considerations

  2010influential citation
• [Analysis of antiparkinsonian drug reduction after bilateral subthalamic deep brain stimulation].

  2010cites this paper
• The effect of medicare's new technology add-on payment policy.

  2010influential citation
• Einfluss von L-Dopa und der Stimulation des Nucleus subthalamicus auf qualitative und quantitative Bewegungsparameter bei Parkinson- Patienten

  2010influential citation
• Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study.

  2010cites this paper
• Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis

  2010cites this paper
• DEEP BRAIN STIMULATION IN MOVEMENT DISORDERS

  2010cites this paper
• Deep brain stimulation for cluster headache.

  2009cites this paper
• Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease.

  2009cites this paper
• Preparing the ethical future of deep brain stimulation.

  2009cites this paper
• [Review of the economic evidence on the use of deep brain stimulation in late stage Parkinson's disease].

  2009cites this paper
• Development of the Wireless Instantaneous Neurotransmitter Concentration System for intraoperative neurochemical monitoring using fast-scan cyclic voltammetry.

  2009cites this paper
• Mély agyi stimuláció : egy új perspektíva a mozgászavarok kezelésében

  2009cites this paper
• Comparison of Symptomatic Effects Deep Brain Stimulation Treating Patients with Deep Brain Stimulation or Duodopa – Pros and Cons Deep Brain Stimulation and Duodopa

  2008cites this paper
• Tiefe Hirnstimulation in der Therapie des langjährigen Morbus Parkinson

  2008cites this paper
• Experience with Medicare's new technology add-on payment program.

  2008cites this paper
• [Special aspects of patient care after implantation of deep-brain-stimulator].

  2008cites this paper
• Quality of Life and Cost Effectiveness of Deep Brain Stimulation in Movement Disorders

  2008cites this paper
• Deep Brain Stimulation: an underused panacea?

  2008cites this paper
• Fast-track programming and rehabilitation model: a novel approach to postoperative deep brain stimulation patient care.

  2007cites this paper
• Globus pallidus deep brain stimulators for a case of severe neuroleptic-related dystonia and dyskinesia

  2007cites this paper
• DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE

  2007cites this paper
• A guide to deep brain stimulation surgery: A treatment for Parkinson's disease

  2007cites this paper
• Deep Brain Stimulation and the Role of the Neuropsychologist

  2007cites this paper
• Treating Patients with Deep Brain Stimulation or Duodopa - Pros and Cons

  2007cites this paper
• Subthalamic nucleus stimulation in Parkinson's disease

  2007cites this paper
• Deep brain stimulation: indications and evidence

  2007cites this paper
• Prospective comparative study on cost‐effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease

  2007cites this paper
• Bispectral Index Monitoring Does Not Improve Anesthesia Performance in Patients with Movement Disorders Undergoing Deep Brain Stimulating Electrode Implantation

  2007influential citation
• Operative and hardware complications of deep brain stimulation for movement disorders

  2006cites this paper
• „Schlaf-Wach-Schlaf“-Technik zur CS Wachkraniotomie

  2006cites this paper
• Criteria for deep-brain stimulation in Parkinson’s disease: review and analysis

  2006cites this paper
• A Review of the Health-Related Quality of Life and Economic Impact of Parkinson’s Disease

  2006cites this paper
• Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson’s disease: one year follow-up of a randomised observer-blind multi centre trial

  2006cites this paper
• ["Asleep-awake-asleep"-anaesthetic technique for awake craniotomy].

  2006cites this paper
• DEEP BRAIN STIMULATION OF THE SUBTHALAMIC NUCLEUS IN PARKINSON ’ S DISEASE

  2006cites this paper
• Deep brain stimulation for the symptoms of Parkinson's disease

  2006cites this paper
• Improvements in motor behavioral tests during deep brain stimulation of the subthalamic nucleus in rats with different degrees of unilateral parkinsonism.

  2006cites this paper
• Subthalamic nucleus stimulation: improvements in outcome with reprogramming.

  2006cites this paper
• Deep-brain stimulation in Parkinson's disease: long-term efficacy and safety – What happened this year?

  2005cites this paper
• Laser literature watch.

  2005cites this paper